High-dose toremifene as first-line treatment of metastatic breast cancer resistant to adjuvant aromatase inhibitor: A multicenter phase II study
about
A computational framework to infer human disease-associated long noncoding RNAsThe discovery and development of selective estrogen receptor modulators (SERMs) for clinical practiceToremifene in the treatment of breast cancerHigh-dose toremifene for fulvestrant-resistant metastatic breast cancer: a report of two cases.Aptamer-Assisted Detection of the Altered Expression of Estrogen Receptor Alpha in Human Breast CancerIn silico selection of an aptamer to estrogen receptor alpha using computational docking employing estrogen response elements as aptamer-alike molecules.
P2860
High-dose toremifene as first-line treatment of metastatic breast cancer resistant to adjuvant aromatase inhibitor: A multicenter phase II study
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
High-dose toremifene as first- ...... : A multicenter phase II study
@ast
High-dose toremifene as first- ...... : A multicenter phase II study
@en
type
label
High-dose toremifene as first- ...... : A multicenter phase II study
@ast
High-dose toremifene as first- ...... : A multicenter phase II study
@en
prefLabel
High-dose toremifene as first- ...... : A multicenter phase II study
@ast
High-dose toremifene as first- ...... : A multicenter phase II study
@en
P2093
P2860
P356
P1433
P1476
High-dose toremifene as first- ...... : A multicenter phase II study
@en
P2093
Hironobu Kobayashi
Kazuki Yokoi
Keitaro Kamei
Masaki Wada
Masataka Sawaki
Motoi Yoshihara
Mototsugu Ohno
Tsuneo Imai
Yasuyuki Sato
Yutaka Mizuno
P2860
P356
10.3892/OL.2011.449
P577
2011-10-19T00:00:00Z